PHAXIAM Therapeutics (PHXM) News Today → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free PHXM Stock Alerts $3.10 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | finanznachrichten.dePhaxiam Therapeutics S.A.: PHAXIAM provides Business and Financial Update for the First Quarter of 2024May 15, 2024 | globenewswire.comPHAXIAM provides Business and Financial Update for the First Quarter of 2024April 15, 2024 | msn.comPhaxiam enrols first patient in endocarditis infection studyApril 15, 2024 | globenewswire.comPHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureusApril 5, 2024 | finanznachrichten.dePhaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)April 5, 2024 | globenewswire.comPHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)March 23, 2024 | seekingalpha.comONCT Oncternal Therapeutics, Inc.March 20, 2024 | globenewswire.comPHAXIAM Announces 2023 Full-Year Results and Provides Business UpdateMarch 11, 2024 | finanznachrichten.dePhaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketMarch 11, 2024 | markets.businessinsider.comPhaxiam Therapeutics Says Delisting Of ADSs From Nasdaq EffectiveMarch 11, 2024 | globenewswire.comPHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketMarch 5, 2024 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital - February 29, 2024February 21, 2024 | marketbeat.comTrading was temporarily halted for "PHXM" at 09:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "PHXM" at 04:02 PM with a stated reason of "News pending."February 20, 2024 | globenewswire.comPHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketFebruary 7, 2024 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital - January 31, 2024January 19, 2024 | finanznachrichten.dePhaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024January 18, 2024 | finance.yahoo.comPHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024January 3, 2024 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital - December 31, 2023December 6, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital - November 30, 2023November 28, 2023 | lse.co.ukPhaxiam Therapeutics Share Price (PHXM.PA)November 15, 2023 | finanznachrichten.dePhaxiam Therapeutics S.A.: PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023November 14, 2023 | morningstar.comPHAXIAM Therapeutics SA ADR PHXMNovember 14, 2023 | finance.yahoo.comPHAXIAM Provides Business and Financial Update for the Third Quarter of 2023November 14, 2023 | marketbeat.comTrading was temporarily halted for "PHXM" at 10:11 AM with a stated reason of "LULD pause."November 11, 2023 | morningstar.comPHAXIAM Therapeutics SA ADRNovember 7, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital _ October 31, 2023October 29, 2023 | investing.comPhaxiam Therapeutics SA DRC (PHXM)October 24, 2023 | finance.yahoo.comPHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureusOctober 23, 2023 | finanznachrichten.dePhaxiam Therapeutics S.A.: TP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a "Buy" recommendationOctober 23, 2023 | finance.yahoo.comTP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a “Buy” recommendationOctober 23, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital _September 30, 2023October 9, 2023 | markets.businessinsider.comPHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strainsOctober 4, 2023 | finance.yahoo.comPHAXIAM Receives Compliance Notice from NasdaqOctober 3, 2023 | finanznachrichten.dePhaxiam Therapeutics S.A.: PHAXIAM Therapeutics and Vetophage Announce Strategic Research CollaborationOctober 3, 2023 | finance.yahoo.comPHAXIAM Therapeutics and Vetophage Announce Strategic Research CollaborationSeptember 22, 2023 | investing.comPHAXIAM Therapeutics SA (PHXM)September 22, 2023 | markets.businessinsider.comPHAXIAM Provides Business and Financial Update For the First Half of 2023September 21, 2023 | finance.yahoo.comPHAXIAM Therapeutics S.A. (PHXM)September 19, 2023 | marketbeat.comTrading was temporarily halted for "PHXM" at 09:09 AM with a stated reason of "LULD pause." Trading set to resume at 09:09 AM. September 19, 2023 | marketbeat.comTrading was temporarily halted for "PHXM" at 09:09 AM with a stated reason of "LULD pause."September 18, 2023 | finance.yahoo.comPHAXIAM Therapeutics announces the completion of its reverse share splitSeptember 11, 2023 | benzinga.comPHAXIAM Therapeutics Stock (NASDAQ:PHXM), Earnings Estimates, EPS, and RevenueSeptember 5, 2023 | finance.yahoo.comPHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferencesAugust 10, 2023 | investorplace.comWhy Is PHAXIAM Therapeutics (PHXM) Stock Up 37% Today? Get PHAXIAM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PHXM and its competitors with MarketBeat's FREE daily newsletter. Email Address The CHIPS Act Motherlode (Ad)If you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this. Click here to see my #1 investment for 2024. PHXM Media Mentions By Week PHXM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHXM News Sentiment▼0.000.42▲Average Medical News Sentiment PHXM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHXM Articles This Week▼21▲PHXM Articles Average Week Get PHAXIAM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PHXM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kaleido Biosciences News Today LianBio News Today Guardion Health Sciences News Today Moleculin Biotech News Today BioCardia News Today MIRA Pharmaceuticals News Today NantHealth News Today BioNexus Gene Lab News Today Eterna Therapeutics News Today Genetic Technologies News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHXM) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PHAXIAM Therapeutics S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.